Performance Assessment of ChatGPT versus Bard in Detecting Alzheimer’s Dementia

Author:

B.T Balamurali1ORCID,Chen Jer-Ming1ORCID

Affiliation:

1. Science, Mathematics & Technology (SMT), Singapore University of Technology & Design, 8 Somapah Rd, Singapore 487372, Singapore

Abstract

Large language models (LLMs) find increasing applications in many fields. Here, three LLM chatbots (ChatGPT-3.5, ChatGPT-4, and Bard) are assessed in their current form, as publicly available, for their ability to recognize Alzheimer’s dementia (AD) and Cognitively Normal (CN) individuals using textual input derived from spontaneous speech recordings. A zero-shot learning approach is used at two levels of independent queries, with the second query (chain-of-thought prompting) eliciting more detailed information than the first. Each LLM chatbot’s performance is evaluated on the prediction generated in terms of accuracy, sensitivity, specificity, precision, and F1 score. LLM chatbots generated a three-class outcome (“AD”, “CN”, or “Unsure”). When positively identifying AD, Bard produced the highest true-positives (89% recall) and highest F1 score (71%), but tended to misidentify CN as AD, with high confidence (low “Unsure” rates); for positively identifying CN, GPT-4 resulted in the highest true-negatives at 56% and highest F1 score (62%), adopting a diplomatic stance (moderate “Unsure” rates). Overall, the three LLM chatbots can identify AD vs. CN, surpassing chance-levels, but do not currently satisfy the requirements for clinical application.

Publisher

MDPI AG

Reference52 articles.

1. Family Caregivers of People with Dementia;Brodaty;Dialogues Clin. Neurosci.,2009

2. Forecasting the Global Burden of Alzheimer’s Disease;Brookmeyer;Alzheimer’s Dement.,2007

3. Global and Regional Projections of the Economic Burden of Alzheimer’s Disease and Related Dementias from 2019 to 2050: A Value of Statistical Life Approach;Nandi;EClinicalMedicine,2022

4. Dementia Prevention, Intervention, and Care: 2020 Report of the Lancet Commission;Livingston;Lancet,2020

5. Clinical Classification of Memory and Cognitive Impairment with Multimodal Digital Biomarkers;Banks;Alzheimer’s Dement.,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3